Physician profile
Ben M Treen
NPI 1457466971
$1,882.42
in general payments reported to CMS, 2019-2025
18 companies · $158 in 2025
The $158 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $597 · 2020: $39.68 · 2021: $198 · 2022: $715 · 2023: $86.20 · 2024: $88.39 · 2025: $158.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $332.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $332.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $730.48 | 2019-2025 | Rinvoq |
| Kerecis Limited | $301.20 | 2022-2025 | Kerecis Surgiclose, Kerecis Omega3 Surgiclose, Kerecis Graftguide |
| Celgene Corporation | $148.24 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $146.25 | 2019-2022 | |
| Janssen Biotech, INC. | $131.08 | 2022-2025 | Tremfya, Simponi, Stelara |
| Pfizer INC. | $107.42 | 2019-2025 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $53.39 | 2019 | |
| Lilly USA, LLC | $37.33 | 2021-2025 | Taltz |
| Leo Pharma INC. | $37.29 | 2019-2020 | |
| Ucb, INC. | $32.84 | 2024-2025 | Bimzelx |
| Sun Pharmaceutical Industries INC. | $32.67 | 2022-2024 | |
| Incyte Corporation | $23.41 | 2023 | Opzelura |
| Dusa Pharmaceuticals, INC. | $22.99 | 2019 | |
| Organogenesis INC. | $19.50 | 2021 | |
| Melinta Therapeutics, LLC | $15.92 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $15.62 | 2024 | Otezla |
| Galderma Laboratories, L.P. | $14.25 | 2025 | Nemluvio |
| Genzyme Corporation | $12.54 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ben Treen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.